Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 63-72

  Braun, Andrea B ^a   Gibbons, Fiona K ^d   Litonjua, Augusto A ^b   Giovannucci, Edward ^e   Christopher, Kenneth B ^a,c  

^a Renal Division   (United States)

^b Pulmonary and Critical Care Division   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

25 hydroxyvitamin D; Epidemiology; Mortality; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CREATININE;

ACUTE KIDNEY FAILURE; ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; ETHNICITY; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POVERTY; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; SEPSIS; SEX DIFFERENCE; SOCIAL STATUS; SURGICAL PATIENT; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84055161203     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822d74f3     Document Type: Article

References (104)

1. Fraser DR: Regulation of the metabolism of vitamin D. Physiol Rev 1980; 60:551-613
2. Raiten DJ, Picciano MF: Vitamin D and health in the 21st century: Bone and beyond. Executive summary. Am J Clin Nutr 2004; 80:1673S-1677S
3. Holick MF: Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79:362-371
4. Teegarden D, Donkin SS: Vitamin D: Emerging new roles in insulin sensitivity. Nutr Res Rev 2009; 22:82-92
5. Autier P, Gandini S: Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167:1730-1737
6. Lee P, Eisman JA, Center JR: Vitamin D deficiency in critically ill patients. N Engl J Med 2009; 360:1912-1914
7. van den Berghe G, Weekers F, Baxter RC, et al: Five-day pulsatile gonadotropinreleasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab 2001; 86:3217-3226
8. van den Berghe G, Wouters P, Weekers F, et al: Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 1999; 84:1311-1323
9. Van den Berghe G, Baxter RC, Weekers F, et al: The combined administration of GHreleasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 2002; 56:655-669
10. Nierman DM, Mechanick JI: Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. Chest 2000; 118:761-766
11. Jeng L, Yamshchikov AV, Judd SE, et al: Alterations in vitamin D status and antimicrobial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7:28
12. Giovannucci E, Liu Y, Hollis BW, et al: 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008; 168:1174-1180
13. Braun A, Chang D, Mahadevappa K, et al: Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med 2011; 39:671-677
14. Jones G: Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008; 88: 582S-586S
15. Norman AW: From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88:491S-499S
16. Nalichowski R, Keogh D, Chueh HC, et al: Calculating the benefits of a Research Patient Data Repository. AMIA Annu Symp Proc 2006:1044
17. Beier K, Eppanapally S, Bazick HS, et al: Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of "normal" creatinine. Crit Care Med 2011; 39:305-313
18. Waikar SS, Mount DB, Curhan GC: Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 2009; 122:857-865
19. Waikar SS, Wald R, Chertow GM, et al: Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol 2006; 17:1688-1694
20. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-383
21. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-619
22. Quan H, Sundararajan V, Halfon P, et al: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43:1130-1139
23. Bureau of the Census. Census summary tape, file 3A (STF 3A). Washington, DC, US Department of Commerce, 1990
24. Krieger N, Chen JT, Waterman PD, et al: Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: Does the choice of area-based measure and geographic level matter?: The Public Health Disparities Geocoding Project. Am J Epidemiol 2002; 156:471-482
25. Krieger N, Chen JT, Waterman PD, et al: Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: The Public Health Disparities Geocoding Project. Am J Public Health 2005; 95: 312-323
26. Nandi A, Glass TA, Cole SR, et al: Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol 2010; 171:391-398
27. Cunradi CB, Caetano R, Clark C, et al: Neighborhood poverty as a predictor of intimate partner violence among White, Black, and Hispanic couples in the United States: A multilevel analysis. Ann Epidemiol 2000; 10:297-308
28. Polednak AP: Stage at diagnosis of prostate cancer in Connecticut by poverty and race. Ethn Dis 1997; 7:215-220
29. Ensminger ME, Lamkin RP, Jacobson N: School leaving: A longitudinal perspective including neighborhood effects. Child Dev 1996; 67:2400-2416
30. McWhorter WP, Schatzkin AG, Horm JW, et al: Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 1989; 63:982-987
31. Breen N, Figueroa JB: Stage of breast and cervical cancer diagnosis in disadvantaged neighborhoods: A prevention policy perspective. Am J Prev Med 1996; 12:319-326
32. Krieger N, Waterman PD, Chen JT, et al: Monitoring socioeconomic inequalities in sexually transmitted infections, tuberculosis, and violence: Geocoding and choice of area-based socioeconomic measures-the public health disparities geocoding project (US). Public Health Rep 2003; 118:240-260
33. Subramanian SV, Chen JT, Rehkopf DH, et al: Racial disparities in context: A multilevel analysis of neighborhood variations in poverty and excess mortality among black populations in Massachusetts. Am J Public Health 2005; 95:260-265
34. Krieger N, Chen JT, Waterman PD, et al: Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: The Public Health Disparities Geocoding Project (US). J Epidemiol Community Health 2003; 57:186-199
35. Krieger N, Zierler S, Hogan J, et al: Geocoding and measurement of neighborhood socioeconomic position: A US Perspective. In: Neighborhoods and Health. Kawachi I, Berkman L (Eds). New York, NY, Oxford University Press, 2003, pp 147-178
36. Wilson W: The Truly Disadvantaged. Chicago, IL, University of Chicago Press, 1987
37. Saunders MR, Cagney KA, Ross LF, et al: Neighborhood poverty, racial composition and renal transplant waitlist. Am J Transplant 2010; 10:1912-1917
38. Massey D, Denton N: American Apartheid: Segregation and Making of the Underclass. Cambridge, MA, Harvard University Press, 1993
39. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
40. Rapoport J, Gehlbach S, Lemeshow S, et al: Resource utilization among intensive care patients. Managed care vs traditional insurance. Arch Intern Med 1992; 152: 2207-2212
41. Cowper DC, Kubal JD, Maynard C, et al: A primer and comparative review of major US mortality databases. Ann Epidemiol 2002; 12:462-468
42. Sohn MW, Arnold N, Maynard C, et al: Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr 2006; 4:2
43. Schisterman EF, Whitcomb BW: Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr 2004; 2:2
44. Newman TB, Brown AN: Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc 1997; 4:233-237
45. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assn 1958; 53:457-481
46. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-454
47. Weiss G, Bogdan C, Hentze MW: Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997; 158: 420-425
48. Tsai K, Hsu T, Kong C, et al: Is the endogenous peroxyl-radical scavenging capacity of plasma protective in systemic inflammatory disorders in humans? Free Radic Biol Med 2000; 28:926-933
49. Ribeiro Nogueira C, Ramalho A, Lameu E, et al: Serum concentrations of vitamin A and oxidative stress in critically ill patients with sepsis. Nutr Hosp 2009; 24:312-317
50. Goode HF, Cowley HC, Walker BE, et al: Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23:646-651
51. Darmon N, Drewnowski A: Does social class predict diet quality? Am J Clin Nutr 2008; 87:1107-1117
52. Horner RD, Lawler FH, Hainer BL: Relationship between patient race and survival following admission to intensive care among patients of primary care physicians. Health Serv Res 1991; 26:531-542
53. Carthy EP, Yamashita W, Hsu A, et al: 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 1989; 13:954-959
54. Levin A, Li YC: Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease? Kidney Int 2005; 68:1973-1981
55. Deluca HF, Cantorna MT: Vitamin D: Its role and uses in immunology. FASEB J 2001; 15:2579-2585
56. Gysemans CA, Cardozo AK, Callewaert H, et al: 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: Implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005; 146:1956-1964
57. Holick MF: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81:353-373
58. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al: Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002; 76:187-192
59. Ginde AA, Mansbach JM, Camargo CA Jr: Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169:384-390
60. Chan TY: Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int 2000; 66:476-478
61. Yener E, Coker C, Cura A, et al: Lymphocyte subpopulations in children with vitamin D deficient rickets. Acta Paediatr Jpn 1995; 37:500-502
62. van Etten E, Mathieu C: Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol 2005; 97:93-101
63. Mora JR, Iwata M, von Andrian UH: Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat Rev Immunol 2008; 8:685-698
64. Kankova M, Luini W, Pedrazzoni M, et al: Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 1991; 73:466-471
65. Liu PT, Stenger S, Tang DH, et al: Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179: 2060-2063
66. Liu PT, Stenger S, Li H, et al: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-1773
67. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357:266-281
68. Bhalla AK, Amento EP, Krane SM: Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 1986; 98:311-322
69. Dürr UH, Sudheendra US, Ramamoorthy A: LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 2006; 1758: 1408-1425
70. Zanetti M: Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004; 75:39-48
71. Wang TT, Nestel FP, Bourdeau V, et al: Cutting edge: 1,25- dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173: 2909-2912
72. Meehan MA, Kerman RH, Lemire JM: 1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol 1992; 140: 400-409
73. Gregori S, Giarratana N, Smiroldo S, et al: A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002; 51:1367-1374
74. Gregori S, Casorati M, Amuchastegui S, et al: Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167:1945-1953
75. Kinsey GR, Sharma R, Huang L, et al: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009; 20:1744-1753
76. Murphy TJ, Ni Choileain N, Zang Y, et al: CD4+CD25+ regulatory T cells control in-nate immune reactivity after injury. J Immunol 2005; 174:2957-2963
77. McHugh RS, Shevach EM: The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol 2002; 110:693-702
78. Monneret G, Debard AL, Venet F, et al: Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsisinduced immunoparalysis. Crit Care Med 2003; 31:2068-2071
79. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
80. Mannick JA, Rodrick ML, Lederer JA: The immunologic response to injury. J Am Coll Surg 2001; 193:237-244
81. Moore FA, Sauaia A, Moore EE, et al: Postinjury multiple organ failure: A bimodal phenomenon. J Trauma 1996; 40: 501-510; discussion 510-512
82. Goldstein LB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: Effect of modifier codes. Stroke 1998; 29:1602-1604
83. Iezzoni LI, Burnside S, Sickles L, et al: Coding of acute myocardial infarction. Clinical and policy implications. Ann Intern Med 1988; 109:745-751
84. Lee DS, Donovan L, Austin PC, et al: Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 2005; 43:182-188
85. Levy AR, Tamblyn RM, Fitchett D, et al: Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. Can J Cardiol 1999; 15:1277-1282
86. Winkelmayer WC, Schneeweiss S, Mogun H, et al: Identification of individuals with CKD from Medicare claims data: A validation study. Am J Kidney Dis 2005; 46: 225-232
87. Humphries KH, Rankin JM, Carere RG, et al: Co-morbidity data in outcomes research: Are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol 2000; 53:343-349
88. Kieszak SM, Flanders WD, Kosinski AS, et al: A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol 1999; 52:137-142
89. Moreno RP, Metnitz PG, Almeida E, et al: SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005; 31:1345-1355
90. Sibbald W: Evaluating critical care: Using health services research to improve quality. In: Update in Intensive Care Medicine. Vincent JL (Ed). Berlin Heidelberg, Springer-Verlag, 2001
91. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
92. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
93. Quach S, Hennessy DA, Faris P, et al: A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients. BMC Health Serv Res 2009; 9:129
94. Akbari A, Swedko PJ, Clark HD, et al: Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med 2004; 164:1788-1792
95. Guessous I, McClellan W, Vupputuri S, et al: Low documentation of chronic kidney disease among high-risk patients in a managed care population: A retrospective cohort study. BMC Nephrol 2009; 10:25-26
96. Hoste EA, Damen J, Vanholder RC, et al: Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant 2005; 20:747-753
97. Kern EF, Maney M, Miller DR, et al: Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res 2006; 41:564-580
98. Stevens LA, Fares G, Fleming J, et al: Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol 2005; 16:2439-2448
99. Gentile G, Postorino M, Mooring RD, et al: Estimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital. BMC Nephrol 2009; 10:24
100. Zager S, Mendu ML, Chang D, et al: Neighborhood poverty rate and mortality in patients receiving critical care in the academic medical center setting. Chest 2011; 139:1368-1379
101. Gottlieb SS: Dead is dead-artificial definitions are no substitute. Lancet 1997; 349: 662-663
102. Lauer MS, Blackstone EH, Young JB, et al: Cause of death in clinical research: Time for a reassessment? J Am Coll Cardiol 1999; 34:618-620
103. Preen DB, Holman CD, Spilsbury K, et al: Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol 2006; 59:940-946
104. Mata-Granados JM, Vargas-Vasserot J, Ferreiro-Vera C, et al: Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LCMS/MS method. J Steroid Biochem Mol Biol 2010; 121:452-455